Cooper Companies (NASDAQ:COO) Director Walter Rosebrough Jr Acquires 3,000 Shares of Stock

Key Points

• Director Walter Rosebrough Jr. purchased 3,000 Cooper Companies shares at an average $54.29 each, investing $162,870 and increasing his holdings by 17.65% to 20,000 shares.
• Cooper Companies shares fell 1.8% to $53.27, near their one-year low, despite quarterly EPS of $1.15 beating estimates; revenue of $1.07 billion fell short of expectations.
• The board authorized a $3 billion share-buyback program covering up to 22.7% of outstanding shares, while the company faces weaker contact-lens demand and reduced fiscal 2026 earnings and revenue guidance.

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) Director Walter Rosebrough, Jr. bought 3,000 shares of the business's stock in a transaction on Monday, September 14th. The shares were purchased at an average cost of $54.29 per share, for a total transaction of $162,870.00. Following the completion of the purchase, the director owned 20,000 shares in the company, valued at approximately $1,085,800. This trade represents a 17.65% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Cooper Companies Stock Down 1.8%

Shares of Cooper Companies stock traded down $0.95 during midday trading on Tuesday, hitting $53.27. The company's stock had a trading volume of 4,414,742 shares, compared to its average volume of 2,501,526. The firm has a market capitalization of $10.13 billion, a P/E ratio of 18.18, a PEG ratio of 2.19 and a beta of 0.82. The stock has a 50-day simple moving average of $71.25 and a 200-day simple moving average of $69.40. The company has a quick ratio of 0.73, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 1-year low of $51.01 and a 1-year high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.03. The business had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%.Cooper Companies's revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 earnings per share. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 4.53 earnings per share for the current year.

Cooper Companies declared that its board has authorized a stock buyback plan on Wednesday, September 9th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the medical device company to reacquire up to 22.7% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board of directors believes its stock is undervalued.

Cooper Companies News Roundup

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Three directors purchased a combined 24,701 COO shares worth approximately $1.33 million at prices ranging from $53.18 to $54.29. The insider buying, including a 90% increase in Lawrence Kurzius’s holdings, may suggest that directors view the recent selloff as an attractive entry point. SEC insider purchase filing
• Neutral Sentiment: An investment analysis argued that Cooper Companies is becoming more compelling at its lower valuation. That view could support the stock if investors conclude that the weaker demand environment is temporary, although it does not change the company’s reduced guidance. Cooper Companies valuation analysis
• Negative Sentiment: Cooper cut fiscal 2026 adjusted EPS guidance to $4.51–$4.55 from $4.58–$4.66 and revenue guidance to $4.23–$4.25 billion from $4.29–$4.32 billion. The reductions reflect slowing contact-lens demand, particularly affecting the CooperVision business. Cooper Companies demand outlook
• Negative Sentiment: Reports said third-quarter results revealed U.S. channel inventory destocking and other negative surprises, intensifying concerns about near-term sales and distributor demand. A law firm has also announced an investigation into whether Cooper issued materially misleading business information, adding potential legal and reputational risk, though no wrongdoing has been established. Cooper Companies inventory report Rosen Law investigation announcement

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Algert Global LLC bought a new position in Cooper Companies during the second quarter valued at about $7,655,000. BlackRock Inc. bought a new stake in shares of Cooper Companies during the 2nd quarter worth about $1,077,762,000. Heartland Advisors Inc. bought a new stake in shares of Cooper Companies during the 4th quarter worth about $15,348,000. Tocqueville Asset Management L.P. acquired a new position in shares of Cooper Companies during the 2nd quarter valued at about $1,502,000. Finally, National Pension Service raised its stake in shares of Cooper Companies by 9,314.0% in the 2nd quarter. National Pension Service now owns 526,149 shares of the medical device company's stock valued at $37,730,000 after acquiring an additional 520,560 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently commented on COO. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a report on Wednesday, May 27th. BNP Paribas Exane dropped their price objective on shares of Cooper Companies from $95.00 to $92.00 and set an "outperform" rating on the stock in a research note on Monday, June 8th. Wall Street Zen downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a research report on Saturday. Needham & Company LLC decreased their target price on shares of Cooper Companies from $86.00 to $73.00 and set a "buy" rating for the company in a research note on Thursday, September 10th. Finally, Stifel Nicolaus set a $70.00 price target on shares of Cooper Companies and gave the company a "buy" rating in a report on Thursday, September 10th. Five research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat, Cooper Companies presently has an average rating of "Hold" and an average price target of $71.47.

Cooper Companies Company Profile

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.